Implantable neural stimulation device

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front perspective of an implantable neural stimulation device showing my new design;

FIG. 2 is a back elevation thereof;

FIG. 3 is a front elevation thereof;

FIG. 4 is a right side elevation thereof;

FIG. 5 is a left side elevation thereof;

FIG. 6 is a top elevation thereof;

FIG. 7 is a bottom elevation thereof; and,

FIG. 8 is a back perspective thereof.

The broken lines illustrate portions of the implantable neural stimulation device and form no part of the claimed design.

Claims

The ornamental design for the implantable neural stimulation device, as shown and described.

Referenced Cited
U.S. Patent Documents
D337820 July 27, 1993 Hooper
5313953 May 24, 1994 Yomotov et al.
6026328 February 15, 2000 Peckham et al.
8929986 January 6, 2015 Parker et al.
D736383 August 11, 2015 Parker
20100019985 January 28, 2010 Bashyam et al.
20100197174 August 5, 2010 Lahti
20100234921 September 16, 2010 Torgerson
20110004279 January 6, 2011 North
20110065301 March 17, 2011 Boyd
20110190833 August 4, 2011 Ries et al.
20110190842 August 4, 2011 Johnson et al.
20140067354 March 6, 2014 Kaula
20170072199 March 16, 2017 Biele
20170100597 April 13, 2017 Barror et al.
20170303424 October 19, 2017 Bobgan et al.
20190134386 May 9, 2019 Romo-Nava
20190175904 June 13, 2019 Baru
20200001094 January 2, 2020 Iyer
20200155833 May 21, 2020 Villarta
Foreign Patent Documents
2004087256 October 2004 WO
WO-2010051123 May 2010 WO
Other references
  • Youtube, “Special Device May Help Alleviate Back Pain”, first available Jun. 26, 2017. (https://www.youtube.com/watch?v=fstvx_CCrjY) (Year: 2017).
  • MPO, “Lasting Impacts: A Roundtable Discussion on Implantable Medical Technology”, first available Sep. 1, 2017. (https://www.mpo-mag.com/issues/2017-09-01/view_features/lasting-impacts-a-roundtable-discussion-on-implantable-medical-technology/) (Year: 2017).
  • Yahoo Finance, “3 Reasons Why Nevro Corp. Was Downgraded By Morgan Stanley”, first available Jul. 2, 2018. (https://finance.yahoo.com/news/3-reasons-why-nevro-corp-160116752.html?soc_src=social-sh&soc_trk=ma) (Year: 2018).
  • Implantable-Device.com, “FDA Approves breakthrough Optimizer® Smart System”, first available Mar. 22, 2019. (http://www.implantable-device.com/2019/03/22/fda-approves-breakthrough-optimizer-smart-system-delivering-ccm-therapy-for-treatment-of-heart-failure/) (Year: 2019).
  • PCT; International Search Report in the PCT Application No. PCT/AU2019/050665 dated Jul. 11, 2019.
Patent History
Patent number: D953532
Type: Grant
Filed: Mar 2, 2020
Date of Patent: May 31, 2022
Assignee: SALUDA MEDICAL PTY LIMITED (Artarmon)
Inventors: Phil Stallard (Artarmon), Peter Scott Vallack Single (Artarmon)
Primary Examiner: Lauren D McVey
Assistant Examiner: Justin A Johnson
Application Number: 29/726,324
Classifications
Current U.S. Class: Prosthesis Or Implant (D24/155)